Related Experiment Video

Updated: Mar 19, 2026

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.6K

[Kawasaki Disease and Pediatric Multisystem Inflammatory Syndrome in the Aftermath of the Pandemic]

Franco Diaz1

  • 1Hospital El Carmen de Maipú, Santiago, Chile.

Andes Pediatrica : Revista Chilena De Pediatria
|March 17, 2026
PubMed

Insights

Multisystem Inflammatory Syndrome in Children (MIS-C) is rare post-COVID-19 but shares features with Kawasaki disease (KD). Recognizing these similarities is key for accurate diagnosis and treatment in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Pediatric Cardiology
  • Immunology

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) emerged during the COVID-19 pandemic, linked to SARS-CoV-2.
  • MIS-C incidence has decreased, but its clinical management remains challenging due to overlapping symptoms with other pediatric conditions.
  • The Kawasaki disease phenotype of MIS-C (fKD/MIS-C) shares significant clinical and pathophysiological traits with Kawasaki disease (KD).

Purpose of the Study:

  • To highlight the diagnostic and therapeutic challenges posed by MIS-C in the post-pandemic era.
  • To emphasize the importance of differentiating MIS-C, particularly the fKD/MIS-C phenotype, from Kawasaki disease (KD).
  • To underscore the need for optimized diagnostic and therapeutic strategies for both conditions, considering their shared and distinct features.

Main Methods:

  • Comparative analysis of clinical and pathophysiological characteristics between fKD/MIS-C and KD.
  • Review of current evidence regarding the diagnosis, treatment, and follow-up of KD.
  • Assessment of MIS-C management based predominantly on expert recommendations.

Main Results:

  • MIS-C is now rare, but its phenotypic overlap with KD complicates diagnosis and management.
  • Robust evidence exists for KD treatment and follow-up, contrasting with MIS-C's reliance on expert opinion.
  • Key similarities and differences between fKD/MIS-C and KD require careful consideration for patient care.

Conclusions:

  • Accurate differentiation between fKD/MIS-C and KD is crucial for appropriate pediatric disease management.
  • Recognizing shared features can optimize diagnosis, identify at-risk populations, and guide acute-phase therapy.
  • Further research is needed to fully understand the long-term implications of fKD/MIS-C.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
2
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
5
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
430
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
707